Skip to main content

Table 6 Adverse events in the patients receiving external beam radiotherapy (EBRT group, n = 35).

From: Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients

 

RTOG toxicity grade

Adverse events

1

n(%)

2

n(%)

3

n(%)

4

n(%)

Gastrointestinal

    

   Anorexia

9 (25.7%)

3 (8.6%)

1 (2.9%)

 

   Nausea

10 (28.6%)

3 (8.6%)

  

   Vomiting

4 (11.4%)

2 (5.7%)

  

Hepatic

    

   ALT

5 (14.3%)

2 (5.7%)

1 (2.9%)

 

   AST

4 (11.4%)

1 (2.9%)

  

   ALP

5 (14.3%)

2 (5.7%)

1 (2.9%)

 

   Bilirubin

3 (8.6%)

1 (2.9%)

  

Bone Marrow

    

   WBC

4 (11.4%)

2 (5.7%)

  

   RBC

2 (5.7%)

1 (2.9%)

  

   PLT

4 (11.4%)

3 (8.6%)

1 (2.9%)

 
  1. ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; RTOG, Radiation Therapy Oncology Group; WBC, white blood cell; RBC, red blood cell; PLT, platelets.